Can your local pharmacist help fix the primary care crisis?  

Dr. Mina Tadrous, host of I’m Pharmacy, joins us to explore the data behind expanded pharmacy services in Ontario — and what this shift means for the future of healthcare. 

A note that this episode was recorded during the Ontario provincial election. We also make mention of a few acronyms:

UTI: Urinary tract infection

PPIs: Proton pump inhibitors are a class of medications that reduce stomach acid.

ODPRN: Ontario Drug Policy Research Network

Inspire-PHC: Inspire – Primary Health Care supports Ontario researchers with all aspects of their projects related to primary care.

Our Guest:

Mina is an assistant professor at the Leslie Dan Faculty of Pharmacy at the University of Toronto and the Tier 2 Canada Research Chair in Pharmaceutical Policy and Real-world Evidence. He is also co-director of Pharmaceutical Policy and Pharmacy Practice at the Ontario Drug Policy Research Network (ODPRN) and ICES adjunct scientist. Mina leads research focused on evaluating drug policies and post-marketing surveillance of medications. He works closely with policymakers and uses large data sets to answer questions about real-world safety and effectiveness and improving the optimal use of medications.

Check out Mina’s podcast:

https://www.pharmacy.utoronto.ca/about/im-pharmacy-podcast-season-four

Read the Research:

Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: a cross-sectional time-series analysis

Applied Health Research Question (AHRQ) Project (in progress): Evaluating pharmacist scope of practice expansion

EPISODE CREDITS:

Produced, edited and mixed by Will Mcintyre, Richard Villeneuve and Pop Up Podcasting
Artwork designed by Stella-Luna Ha
Music licensed through Melodie Music

LINKS:

Be sure to follow and tag ICES on Bluesky, X, Instagram and LinkedIn. To find out more about our organization, visit us at ices.on.ca